Daily Traders Edge

: Twist Bioscience shares slide 20% after short seller compares synthetic DNA provider to Theranos, calling it a ‘cash-burning inferno’

November 16
06:37 2022

Twist Bioscience Corp. stock slid 20% Tuesday, after a damning short seller report compared the company to the failed blood-testing startup Theranos, calling it a “cash-burning inferno” and a “‘synthetic biology’ swindle.”

Continue Reading At MarketWatch

Related Articles

Newsletter Signup

Sign up for our free newsletter